Entest BioMedical Inc.
Entest BioMedical Announces Intent to Acquire Cancer Research Company Therinject LLC
Published in Vaccine Weekly, November 4th, 2009
Entest BioMedical Inc. (OTCBB: ENTB) announced that it has signed a letter of intent to acquire Therinject LLC. Therinject LLC is involved with Cancer Research, marker testing / development and "bead" formation used in vaccine development. Company Chairman David Koos noted, "Entest BioMedical has already established a joint venture with Therinject LLC and Bio-Matrix Scientific Group Inc. (OTCBB: BMSN). I believe this is an obvious natural fit and removes any potential conflicts between each company's goals."
Therinject's Managing Principal, Steven Josephs, PhD stated, "I have been involved with new develops taking place at Entest for some time. I'm excited that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-11-04)
More Articles from Vaccine Weekly
- Johns Hopkins University Bloomberg School of Public Health
Review: Pneumococcal conjugate vaccines effective at preventing child deaths - Springer
Elderly immune system needs a boost - Allergies
Research from N. Schmitz and co-authors provides new data about allergies - Anthrax Vaccines
Researchers from Kansas State University report on findings in anthrax vaccines - Candidiasis
New findings from S. Havlikova and co-authors describe advances in candidiasis - DNA Vaccines
Researchers at Karolinska Hospital target DNA vaccines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
